When the mechanisms that replicate or repair mitochondrial DNA (mtDNA) fail, it can cause a wide range of syndromes for which ...

Biopharmaceutical company BioVersys has announced the grant of key patent claims in China for BV100, the intravenous ...

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...

Strong revenue performance, including approximately $1.9 million milestone and license ... Dyadic has developed and validated prototypes for four additional enzymes, including RNase Inhibitors and T7 ...

Strong revenue performance, including approximately $1.9 million milestone and license ... Dyadic has developed and validated prototypes for four additional enzymes, including RNase Inhibitors and T7 ...

To implement the blueprint it contains, RNA polymerase is used. The enzyme reads the information stored in the template and makes the corresponding RNA component. Algorithms specifically developed ...

Department of Life Science, Graduate School of Arts and Science, The University of Tokyo, 3-8-1 Komaba, Meguro-ku ... by homologous recombination catalyzed by the proteins, phi29 DNA polymerase, and ...

HMPV primarily affects the upper and lower respiratory tracts and is particularly concerning for vulnerable groups.

Awareness of RNA-based therapies has increased after the widespread adoption of mRNA vaccines against SARS-CoV-2 during the COVID-19 pandemic. These mRNA vaccines had a significant impact on reducing ...

All experimental procedures used in this study were carried out following the Experimental Animal Management Regulations (amendment on 1 March 2017 ... United States). For RNA isolation, the organ ...